Sarah B. Noonberg, Director of Neurogene NGNE, has filed 0 purchases and 1 sale on the open market. The latest trade was on 02/20.

SN

SN

Sarah B. Noonberg

Director

Company

Neurogene NGNE

First filing

23/01/18

Trades

17 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

02/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Metagenomi TherapeuticsMGX	Open-market sale	25/06/06	25/06/09	5,239 sh	$1.75	$9,168.25	−4.6%